Home News Weight Loss After HER2-positive Early Breast Cancer Diagnosis Associated With Worse Outcomes back to News
minute read
A 5% weight loss over 2 years in patients with human epidermal growth factor receptor 2 (HER2)-positive early breast cancer was associated with worse outcomes, according to new research that investigated the body mass index (BMI) data of these patients.
Topics: Press Coverage
13001 East 17th Place
Aurora, CO 80045
303.724.5375
© 2024 The Regents of the University of Colorado, a body corporate. All rights reserved.
Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.
